Found 5 matching trials
RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis PHASE1 RESET-MS: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy ...
Show More Location
Multiple Locations
Learn More & Join Trial
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis PHASE1 RESET-MG: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy ...
Show More Location
University of California Irvine
Learn More & Join Trial
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy PHASE2 RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CAB...
Show More Location
University of California Irvine - Accepting Adult Patients
Learn More & Join Trial
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis PHASE2 RESET-SSc: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy...
Show More Learn More & Join Trial
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus PHASE1 RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy...
Show More Location
University of California Irvine
Learn More & Join Trial